Article Sidebar
Published:
Jul 11, 2024Keywords:
Article Details
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
Chlorhexidine mouthwash and augmentin to prevent Alveolar Osteitis after removal of mandibular third molar: a three-arm placebo- controlled randomized clinical trial
Abstract
Background: Alveolar Osteitis (AO) is a complicated problem that particularly occurs following the surgical removal of teeth resulting in severe pain and repeated practice/hospital visits.
Objectives: The aim of the study was to investigate the role of postoperative Chlorhexidine (CHX) plus Augmentin in preventing Alveolar Osteitis AO after mandibular third molars removal.
Methods: A total of 191 patients were randomly allocated to the CHX group (66 patients) or CHX and Augmentin group (63 patients) and Placebo group (62 patients). One mandibular third molar was removed in one session where surgical standard procedure was followed. All patients were prescribed rescue medication for postoperative pain relief. A postoperative follow up examination was performed on the third and seventh day to evaluate the existing cases of AO.
Results: Group 2 (CHX and Augmentin) showed a significant reduction in AO (P < 0.05) when compared with group 1 (CHX) and group 3 (placebo). Patients have reported CHX side effects like taste alteration, bad taste, and staining.
Conclusion: The combination of CHX plus Augmentin may be useful in reducing the incidence of AO following mandibular third molars extraction.
Keywords: Chlorhexidine; Augmentin; Alveolar osteitis; third molar; extraction.
